Benxu Tan

521 total citations
17 papers, 399 citations indexed

About

Benxu Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Benxu Tan has authored 17 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Benxu Tan's work include RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Benxu Tan is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Benxu Tan collaborates with scholars based in China and United States. Benxu Tan's co-authors include Jiyan Liu, Longhao Li, Xingchen Peng, Dong Hang, Jingmei Su, Feng Zhao, Jun Ge, W. Yao, Jianglong Hou and Feng Gao and has published in prestigious journals such as Cancer, European Journal of Cancer and Frontiers in Physiology.

In The Last Decade

Benxu Tan

17 papers receiving 392 citations

Peers

Benxu Tan

ONCOL

PRM

PFM

Se-Kyung Lee South Korea

Yasuhiko Komiya Japan

Yanyi Xiao China

Xinghao Ai China

Zhengrong Huang China

Iwao Shimomura Japan

Syed F. Zafar United States

Zunlin Zhou China

G. Tartarelli Italy

Wenying Deng China

Se-Kyung Lee South Korea

Benxu Tan

148 ×0.6

138 ×0.8

ONCOL

108 ×1.0

82 ×0.9

PRM

49 ×1.1

PFM

Citations per year, relative to Benxu Tan Benxu Tan (= 1×) peers Se-Kyung Lee

Countries citing papers authored by Benxu Tan

Since Specialization

Citations

This map shows the geographic impact of Benxu Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benxu Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benxu Tan more than expected).

Fields of papers citing papers by Benxu Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benxu Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benxu Tan. The network helps show where Benxu Tan may publish in the future.

Co-authorship network of co-authors of Benxu Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Benxu Tan. A scholar is included among the top collaborators of Benxu Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benxu Tan. Benxu Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Huang, Yu‐Sheng, L. Xia, Jingyi Zhang, et al.. (2022). Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis. Cellular & Molecular Biology Letters. 27(1). 43–43. 43 indexed citations

Peng, Yuan, Yonghong Chen, Xiaoyue Zhang, et al.. (2022). Co‐occurrence of CDKN2A/B and IFN‐I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma. Molecular Oncology. 16(8). 1746–1760. 12 indexed citations

Tang, Yinghong, et al.. (2021). Exercise Enhanced Cardiac Function in Mice With Radiation-Induced Heart Disease via the FNDC5/Irisin-Dependent Mitochondrial Turnover Pathway. Frontiers in Physiology. 12. 739485–739485. 16 indexed citations

He, Mingfeng, Xiaoyue Zhang, Yuan Peng, et al.. (2021). First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis. Cancer Immunology Immunotherapy. 71(6). 1345–1355. 10 indexed citations

Tan, Benxu, Lei Xia, Xianjun Yu, et al.. (2021). PMEPA1 facilitates non-small cell lung cancer progression via activating the JNK signaling pathway. Cancer Biomarkers. 31(3). 203–210. 9 indexed citations

Dong, Yuan, et al.. (2020). Hypoxia‐induced SPOP attenuates the mobility of trophoblast cells through inhibition of the PI3K/AKT/GSK3β pathway. Cell Biology International. 45(3). 599–611. 12 indexed citations

Xie, Wenyue, Benxu Tan, Zhenzhou Yang, et al.. (2020). Nrf2/ARE pathway activation is involved in negatively regulating heat-induced apoptosis in non-small cell lung cancer cells. Acta Biochimica et Biophysica Sinica. 52(4). 439–445. 9 indexed citations

Zhang, Hongbin, Ke Xu, Qin Xiang, et al.. (2020). LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma. Genes & Diseases. 9(1). 151–164. 10 indexed citations

Tan, Benxu, Xuan Jiang, Ruping Wang, et al.. (2019). Genomic Profiling Reveals Synchronous Bilateral Lung Adenocarcinomas With Distinct Driver Alterations of EML4-ALK or TPM3-ROS1 Fusion: A Case Report. Frontiers in Oncology. 9. 1319–1319. 1 indexed citations

10.

Li, Minmin, Tao Zhang, Benxu Tan, Min Yu, & Binglan Zhang. (2019). Role of postoperative adjuvant radiotherapy for locally advanced laryngeal cancer: a meta-analysis. Acta Oto-Laryngologica. 139(2). 172–177. 12 indexed citations

11.

Yu, Min, et al.. (2015). Meta-Analysis of Circulating Endothelial Cells and Circulating Endothelial Progenitor Cells as Prognostic Factors in Lung Cancer. Asian Pacific Journal of Cancer Prevention. 16(14). 6123–6128. 4 indexed citations

12.

Li, Longhao, Dong Hang, Feng Zhao, et al.. (2013). The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil. European Journal of Cancer. 49(7). 1752–1760. 30 indexed citations

13.

Tan, Benxu, Ye Chen, Li V. Yang, et al.. (2011). Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability. Journal of Molecular Medicine. 89(6). 595–602. 66 indexed citations

14.

Tan, Benxu, W. Yao, Jun Ge, et al.. (2011). Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes. Cancer. 117(22). 5103–5111. 144 indexed citations

15.

Gong, Fengming, Xingchen Peng, Benxu Tan, et al.. (2011). Comparative proteomic analysis of irinotecan-sensitive colorectal carcinoma cell line and its chemoresistant counterpart. Anti-Cancer Drugs. 22(6). 500–506. 7 indexed citations

16.

Peng, Xingchen, Meng Qiu, Benxu Tan, et al.. (2011). Different combination schedules of gemcitabine with endostar affect antitumor efficacy. Cancer Chemotherapy and Pharmacology. 69(1). 239–246. 11 indexed citations

17.

Cheng, Ke, Yang Wu, Xingchen Peng, et al.. (2011). Interleukin-15 enhances T-cell responses by stimulation with dendritic cells. Clinical & Translational Oncology. 13(4). 275–280. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact